“FDA Greenlights Pfizer-BioNTech Boosters: Young Kids with Weakened Immunity Get Added Protection”
The US Food and Drug Administration (FDA) has granted emergency use authorization for Pfizer Inc. and BioNTech SE’s COVID-19 bivalent vaccine for immunocompromised children aged six months through four years. This marks the first time a fourth dose of a COVID-19 vaccine has been authorized for young children in this age group. The additional shot […]